DocGo Inc. provided earnings guidance for the year 2024. The revenue expectation for 2024 base businesses going forward, medical transportation and non-migrant mobile health is $280 million to $300 million, in line with previous expectations.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.09 USD | +0.32% |
|
+6.92% | -44.72% |
Jun. 17 | DocGo Inc. Establishes Medical Advisory Board | CI |
May. 09 | Cantor Fitzgerald Adjusts DocGo Price Target to $5 From $11, Maintains Overweight Rating | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.72% | 314M | |
-3.46% | 3B | |
+27.57% | 1.92B | |
0.00% | 1.82B | |
+61.78% | 677M | |
-17.49% | 428M | |
-27.91% | 153M | |
-13.44% | 134M | |
+3.85% | 69.19M |
- Stock Market
- Equities
- DCGO Stock
- News DocGo Inc.
- DocGo Inc. Provides Earnings Guidance for the Year 2024